Bacterial Meningitis
19
4
4
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
5.3%
1 terminated out of 19 trials
90.9%
+4.4% vs benchmark
42%
8 trials in Phase 3/4
40%
4 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (19)
Acute Treatment and Long-term Assessment of Adult Infectious Meningitis
Intracalvariosseous Plus Intravenous Antibiotics for Moderate-to-Severe Bacterial Meningitis
Augmented Renal Clearance in Neurocritical Care
Confirmatory Study of BK1310 in Healthy Infants
Central Nervous System Infections in Denmark
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Driving Reduced AIDS-associated Meningo-encephalitis Mortality
DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants
Early Diagnosis of Native and Device-associated Meningitis
Population Pharmacokinetics of Commonly Used Antimicrobial Agents in Children of Bacterial Meningitis With Augmented Renal Clearance
Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis
Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India
Meningitis With Cerebral Vasculitis in Children
Neonatal Bacterial Meningitis Cohort
Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC
Vitamin d Levels in Children With Bacterial Meningitis
Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan
IHPOTOTAM : Induced HyPOthermia TO Treat Adult Meningitis
Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis